PR Newswire - Sciwind Biosciences Announces Global Licensing and...
HANGZHOU, China, Jan. 10, 2025 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, tod...
Read More

ภาษาไทย
English